$12.34
+0.23 (+1.90%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-83.07%
1Y
-73.34%
YTD
-82.88%
Open$12.15
Previous Close$12.11
Day High$12.49
Day Low$12.15
52W High$73.06
52W Low$11.13
Volume—
Avg Volume121.7K
Market Cap207.15M
P/E Ratio—
EPS$-3.86
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$72.38
Below
SMA 200
$51.57
Below
RSI (14)
65.9
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
7 analysts
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 18.26M | 11.53M | 2.36B |
| Net Income | -48,554,189 | -27,580,642 | -651,372,475 |
| Profit Margin | -265.9% | -252.6% | -27.6% |
| EBITDA | -48,364,498 | -28,999,162 | -865,943,607 |
| Free Cash Flow | — | — | -400,975,764 |
| Rev Growth | +58.4% | +58.4% | +6.9% |
| Debt/Equity | — | — | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |